A61K 31/7064
Containing condensed or non-condensed pyrimidines
Official title: containing condensed or non-condensed pyrimidines
A61K31/7064 (Containing condensed or non-condensed pyrimidines) appears on 3,944 US grants and 7,828 published applications in this corpus.
Search patents in A61K- Granted patents
- 3,944
- Published applications
- 7,828
- Assignees
- 2,644
- Inventors
- 12,582
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1988 | 2 | 0 |
| 1989 | 6 | 0 |
| 1990 | 1 | 0 |
| 1991 | 0 | 0 |
| 1992 | 2 | 0 |
| 1993 | 5 | 0 |
| 1994 | 3 | 0 |
| 1995 | 8 | 0 |
| 1996 | 11 | 0 |
| 1997 | 47 | 0 |
| 1998 | 49 | 0 |
| 1999 | 49 | 0 |
| 2000 | 35 | 0 |
| 2001 | 51 | 21 |
| 2002 | 51 | 99 |
| 2003 | 53 | 148 |
| 2004 | 36 | 158 |
| 2005 | 42 | 207 |
| 2006 | 67 | 219 |
| 2007 | 45 | 190 |
| 2008 | 57 | 152 |
| 2009 | 74 | 211 |
| 2010 | 86 | 242 |
| 2011 | 92 | 229 |
| 2012 | 127 | 213 |
| 2013 | 157 | 349 |
| 2014 | 198 | 450 |
| 2015 | 192 | 384 |
| 2016 | 216 | 444 |
| 2017 | 240 | 428 |
| 2018 | 228 | 356 |
| 2019 | 263 | 453 |
| 2020 | 250 | 429 |
| 2021 | 247 | 480 |
| 2022 | 200 | 488 |
| 2023 | 212 | 461 |
| 2024 | 214 | 403 |
| 2025 | 185 | 361 |
| 2026 | 143 | 253 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Small molecule inhibitors of viral replication6 Oct 2026US 12,751,963 B2The Trustees of Princeton University
- Methods for treating pancreatic cancer and other solid tumors6 Oct 2026US 12,751,991 B2Lisata Therapeutics, Inc.
- Method of predicting therapeutic response and prognosis of metastatic breast cancer to chemotherapeutic agents, and treating metastatic breast cancer6 Oct 2026US 12,753,447 B2Samsung Life Public Welfare Foundation
- NiRAN interfering drugs for SARS-CoV-2 mutant therapy29 Sep 2026US 12,746,251 B2Atea Pharmaceuticals, Inc.
- Methods for X chromosome reactivation29 Sep 2026US 12,746,254 B2The Regents of the University of California
- Sulfurized imidazoles in ophthalmic formulations8 Oct 2026US 2026/0306457 A1Geneiii Biotech Company Ltd.
- Prmt inhibitor compounds and the uses thereof8 Oct 2026US 2026/0306527 A1Purdue Research Foundation
- Anti-cancer treatments and methods of use thereof8 Oct 2026US 2026/0308535 A1
- Methods for treating gastrointestinal inflammatory diseases using alpha-ketoglutarate (akg) modulators1 Oct 2026US 2026/0294856 A1
- Indole lactate for the treatment of multiple sclerosis1 Oct 2026US 2026/0294870 A1The Johns Hopkins University
Most cited
By later US patents
- Bicyclonucleoside and oligonucleotide analogues547US 6,268,490 B1Takeshi Imanishi · 2001
- Anti-PD-L1 antibodies, compositions and articles of manufacture459US 8,217,149 B2Genentech, Inc. · 2012
- Lineage-directed induction of human mesenchymal stem cell differentiation264US 5,736,396 ACase Western Reserve University · 1998
- Maintenance of platelet inhibition during antiplatelet therapy253US 10,022,391 B2Chiesi Farmaceutici S.P. A. · 2018
- Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase223US 7,125,855 B2Merck & Co., Inc. · 2006